Cabiralizumab
Cabiralizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Cabiralizumab is under investigation in clinical trial NCT03502330 (APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma).
| Trade Name | Cabiralizumab |
| Generic | Cabiralizumab |
| Cabiralizumab Other Names | Cabiralizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Cabiralizumab
